SKI Market

A+| A| A-|

Indian Indices

Sensex

74,532.96 325.72
( 0.44%)

Global Indices

Nasdaq

45,612.20 -430.24
(-0.93%)

Dow Jones

6,526.68 -100.81
(-1.52%)

Hang Seng

53,297.18 -1,942.22
(-3.52%)

Nikkei 225

9,927.54 -135.96
(-1.35%)

Forex

USD-INR

93.13 0.41
(0.44%)

EUR-INR

107.17 0.41
(0.39%)

GBP-INR

124.14 0.56
(0.45%)

JPY-INR

0.59 0.00
(0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bharat Immunological & Biological Corporation Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524663

INE994B01014

-7.5352246

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

72.2

EPS(TTM)

Face Value()

Div & Yield %

Back

Alka Securities standalone net profit declines 50.00% in the September 2025 quarter

Nov 15,2025

Net profit of Alka Securities declined 50.00% to Rs 0.01 crore in the quarter ended September 2025 as against Rs 0.02 crore during the previous quarter ended September 2024. Sales remain constant at Rs 0.09 crore in the quarter ended September 2025 and also during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.09	0.09	0
OPM %	44.44	11.11	-
PBDT	0.04	0.02	100
PBT	0.01	0.02	-50
NP	0.01	0.02	-50

74,532.96 325.72 ( 0.44%)

45,612.20 -430.24 (-0.93%)

6,526.68 -100.81 (-1.52%)

53,297.18 -1,942.22 (-3.52%)

9,927.54 -135.96 (-1.35%)

93.13 0.41 (0.44%)

107.17 0.41 (0.39%)

124.14 0.56 (0.45%)

0.59 0.00 (0.73%)